Edgewise Therapeutics, Inc. (EWTX) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 187 transactions totaling $82.7M, demonstrating a bullish sentiment with $35.4M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 473 shares valued at $0.
No significant insider buying has been recorded for EWTX in the recent period.
No significant insider selling has been recorded for EWTX in the recent period.
Based on recent SEC filings, insider sentiment for EWTX is bullish with an Insider Alignment Score of 71/100 and a net flow of $35.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Edgewise Therapeutics, Inc. (EWTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading EWTX stock, having executed 187 transactions in the past 90 days. The most active insider is Peter A. Thompson (Executive), who has made 7 transactions totaling $16.7M.
Get notified when executives and directors at EWTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | C. Fox Jonathan | Executive | Award | 473 | $N/A | $0 | |
| Nov 12, 2025 | J. Russell Alan | Executive | Option Exercise | 100,000 | $0.18 | $18.0K | |
| Nov 12, 2025 | J. Russell Alan | Executive | Sale | 100,000 | $21.12 | $2.1M | Large |
| Nov 11, 2025 | C. Fox Jonathan | Executive | Purchase | 10,700 | $18.64 | $199.4K | |
| Oct 1, 2025 | C. Fox Jonathan | Executive | Award | 728 | $N/A | $0 | |
| Aug 26, 2025 | J. Russell Alan | Executive | Option Exercise | 100,000 | $0.18 | $18.0K | |
| Aug 26, 2025 | J. Russell Alan | Executive | Sale | 100,000 | $14.60 | $1.5M | Large |
| Aug 12, 2025 | M. Donovan Joanne | Executive | Option Exercise | 5,781 | $N/A | $0 | |
| Aug 12, 2025 | M. Donovan Joanne | Executive | Sale | 2,862 | $13.39 | $38.3K | |
| Aug 12, 2025 | Koch Kevin | Executive | Option Exercise | 17,968 | $N/A | $0 | |
| Aug 12, 2025 | Koch Kevin | Executive | Sale | 7,972 | $13.39 | $106.7K | |
| Aug 12, 2025 | J. Russell Alan | Executive | Option Exercise | 5,781 | $N/A | $0 | |
| Aug 12, 2025 | J. Russell Alan | Executive | Sale | 1,907 | $13.39 | $25.5K | |
| Aug 12, 2025 | Michael Carruthers R. | Executive | Sale | 1,428 | $13.39 | $19.1K | |
| Aug 12, 2025 | Michael Carruthers R. | Executive | Option Exercise | 5,781 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 16 | $59.0M | 70.6% |
Sale(S) | 96 | $23.6M | 28.3% |
Exercise(M) | 61 | $942.7K | 1.1% |
Award(A) | 3 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 10 | $0 | 0.0% |
Insiders at Edgewise Therapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 187 transactions totaling $59.0M in purchases versus $23.6M in sales, the net buying activity of $35.4M signals strong executive confidence. Peter A. Thompson (Executive) leads the buying activity with $16.7M in transactions across all time.